Pancreatic Neuroendocrine Tumors

A pancreatic neuroendocrine tumor (pNET) develops from the pancreas's hormone-producing neuroendocrine cells. The first clinical question is not simply where the mass is; it is whether the tumor is secreting a hormone and causing a recognizable syndrome. The second is how aggressively the tumor behaves, determined by differentiation, proliferative grade, receptor expression, and spread. This distinction drives nursing priorities. A small insulinoma can produce recurrent neuroglycopenic emergencies, whereas a non-functional tumor may remain clinically silent until it obstructs nearby structures or metastasizes. Assessment should therefore connect the patient's symptoms to a possible hormone syndrome, confirm that syndrome with targeted biochemical testing, and identify complications such as hypoglycemia, severe acid-related ulceration, secretory diarrhea, thrombosis, or postoperative pancreatic dysfunction.